A detailed history of Robbins Farley LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Robbins Farley LLC holds 42,588 shares of BSX stock, worth $4.37 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares
42,588
Previous 37,522 13.5%
Holding current value
$4.37 Million
Previous $4.03 Million 3.15%
% of portfolio
1.79%
Previous 1.95%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025

BUY
$97.03 - $108.14 $491,553 - $547,837
5,066 Added 13.5%
42,588 $4.16 Million
Q2 2025

Jul 17, 2025

BUY
$89.7 - $107.41 $39,647 - $47,475
442 Added 1.19%
37,522 $4.03 Million
Q1 2025

Apr 16, 2025

BUY
$89.38 - $106.18 $3.31 Million - $3.94 Million
37,080 New
37,080 $3.74 Million
Q2 2024

Jul 16, 2024

BUY
$67.33 - $77.71 $1,009 - $1,165
15 New
15 $1,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Robbins Farley LLC Portfolio

Follow Robbins Farley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robbins Farley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Robbins Farley LLC with notifications on news.